logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
22/06/2026
Market news: Negotiations between the US and Iran are still ongoing.
Latest
1 m ago
Ministry of Transport: By 2025, the total mileage of high-speed railways in the country will exceed 50,000 kilometers, and the volume of commercial freight transport will reach 587 billion tons.
1 m ago
Spot silver rose 1% intraday, now reported at $65.48 per ounce.
2 m ago
The country's first ultra-light eVTOL cross-border insurance lands in Qianhai.
2 m ago
WeChat AI assistant "Xiao Wei" has a small-scale grayscale online launch, AI applications may usher in the best investment hitting area.
3 m ago
Sinobios: The first subject in China's pivotal Phase III clinical trial of IBI3003 for the treatment of relapsed or refractory multiple myeloma in the fourth or fifth line has been dosed.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.